Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma

Oncology

Volumn 59, Issue 1, 2000, Pages 68-74

  Ito, Yasuhiro ^a,b   Takeda, Tsutomu ^a   Sakon, Masato ^b   Monden, Morito ^b   Tsujimoto, Masahiko ^c   Matsuura, Nariaki ^b  

^a Osaka Seamen's Insurance Hospital   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c OSAKA POLICE HOSPITAL   (Japan)

Author keywords

cdc2; Cyclin A; Cyclin B1; Hepatocellular carcinoma; Ki 67; Prognostic factor

Indexed keywords

CYCLIN DEPENDENT KINASE;

ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033916771     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012140     Document Type: Article

References (32)

1. Beasley RP, Hwang L-Y, Lin C-C, Chien C-S: Hepatocellular carcinoma and hepatitis B virus. Lancet 1981;11:1129-1133.
2. Uwaifo AO, Bababunmi EA: Liver carcinogenesis in tropical Africa. IARC Sci Publ 1984;63: 59-88.
3. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y: Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1980; 87:6547-6549.
4. Benvegnu L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cechetto A, Alberti A: Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 1994;74: 2442-2448.
5. Zein NN, Poterucha JJ, Gross JB Jr: Wiesner RH, Therneau TM, Gossard AA, Wendt NK, Mitchell PS, Germer JJ, Persing DH: Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b. Am J Gastroenterol 1996;91:2560-2562.
6. Sasaki K, Murakami T, Kawasaki M: The cell cycle associated change of the Ki-67 reactive nuclear antigen expression. J Cell Physiol 1987; 133:579-584.
7. Ito Y, Matsuura N, Sakon M, Takeda T, Umeshita K, Nagano H, Nakamori S, Dono K, Tsujimoto M, Nakahara M, Nakao K, Monden M: Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma. Br J Cancer, in press.
8. Ito Y, Matsuura N, Sakon M, Miyoshi E, Noda K, Takeda T, Umeshita K, Nagano H, Nakamori S, Dono K, Tsujimoto M, Nakahara M, Nakao K, Taniguchi N, Monden M: Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Hepatology 1999;30:90-99.
9. Pines J, Hunter T: Cyclins A and B1 in the human cell cycle. Ciba Found Symp 1992;170: 187-196.
10. Matsushime H, Ewen ME, Strom DK, Kato JY, Hanks SK, Roussel MF, Sherr CJ: Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 1992;71:323-334.
11. Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T: Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 1992;257:1689-1694.
12. Kanai M, Shiozawa T, Xin L, Nikaido T, Fujii S: Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix. Cancer 1998;82: 1709-1719.
13. Kawamoto H, Koizumi H, Uchikoshi T: Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: Immunocytochemical and quantitative image analyses. Am J Pathol 1997;150:15-23.
14. Walker DH, Maller JL: Role of the cyclin A in the dependence of mitosis on completion of DNA replication. Nature 1991;345:314-317.
15. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G: Cyclin A is required at two points in the human cell cycle. EMBO J 1991;11:961-971.
16. Rosenblatt J, Gu Y, Morgan DO: Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc Natl Acad Sci USA 1992; 89:2824-2828.
17. Furihata M, Ishikawa T, Inoue A, Yoshikawa C, Sonobe H, Ohtsuki Y, Araki K, Ogoshi S: Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma. Clin Cancer Res 1996;2:1781-1785.
18. Dobashi Y, Shoji M, Jiang S-X, Kobayashi M, Kawakubo Y, Kameya T: Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas. Am J Pathol 1998;153:963-972.
19. Volm M, Koomagi R, Mattern J, Stammler G: Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas. Br J Cancer 1997;75:1774-1778.
20. Aaltomaa S, Eskelinen M, Lipponen P: Expression of cyclin A and D proteins in prostate cancer and their relation to clinicopathological variables and patient survival. Prostate 1999; 38:175-182.
21. Kanai M, Shiozawa T, Xin L, Nikaido T, Fujii S: Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix. Cancer 1998;82: 1709-1719.
22. Shiozawa T, Xin L, Nikaido T, Fujii S: Immunohistochemical detection of cyclin A with reference to p53 expression in endometrial endometroid carcinomas. Int J Gynecol Pathol 1997;16:348-353.
23. Renshaw AA, Loughlin KR, Loughlin KR, Dutta A: Cyclin A and MIB1 (Ki67) as markers of proliferative activity in primary renal neoplasms. Mod Pathol 1998;11:963-966.
24. Chao Y, Shih Y-L, Chiu J-H, Chau G-Y, Lui W-Y, Yang WK, Lee S-D, Huang T-S: Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res 1998;58:985-990.
25. Murakami H, Furihata M, Ohtsuki Y, Ogoshi S: Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma. Virchows Arch 1999;434:153-158.
26. Dutta A, Chandra R, Leiter LM, Lester S: Cyclins as markers of tumor proliferation: Immunocytochemical studies in breast cancer. Proc Natl Acad Sci USA 1995;92:5386-5390.
27. Kawamoto H, Koizumi H, Uchikoshi T: Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: Immunocytochemical and quantitative image analyses. Am J Pathol 1997;150:15-23.
28. Wang A, Yoshimi N, Ino N, Tanaka T, Mori H: Overexpression of cyclin B1 in human colorectal cancers. J Cancer Res Clin Oncol 1997;123: 124-127.
29. Liver Cancer Study Group of Japan: The General Rules for the Clinical and Pathological Study of Primary Liver Cancer, ed 3. Tokyo, Kanehara, 1992.
30. Ng IOL, Na J, Lai ESC, Fan ST, Matthew NG: Ki-67 antigen expression in hepatocellular carcinoma using monoclonal antibody MIB1. A comparison with proliferating cell nuclear antigen. Am J Clin Pathol 1995;104:313-318.
31. Agarwal ML, Agarwal A, Taylor WR, Stark GR: p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 1995;92:8493-8497.
32. Gong J, Ardelt B, Traganos F, Darzynkiewics Z: Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. Cancer Res 1994;54:4285-4288.